Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 901–1,000 of 1,000
Probiotics as a Sustainable Approach in Health Enrichment
Rajeev, A., Aiswarya Sudheer, C. K., & Chattopadhyay, I. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.1.02
“115 The potential for the transmission of antibiotic-resistance genes between probiotics and other commensal or pathogenic bacteria found in the gastrointestinal system is another factor pertaining to the safety of bacteria used as probiotics.”
BackgroundZhong, S., Guo, F., Chen, Q., & Zhang, S. (2026) · Intestinal failure. · doi:10.1016/j.intf.2026.100355
Microbiological Modification Therapy For Acute Medical Presentations Of Generalised Anxiety Disorder
Brzezicki, M. A., Celentano, L., Ostrowski, M., & Chakraborty, A. (2020) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.11.67
“These products are widely available in the consumer market and are considered safe to use by public bodies and regulators [44].”
BackgroundButel, M. J., Waligora‐Dupriet, A., & Aires, J. (2025) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(24)48051-5
Commercially available human and animal postbiotics
Pandey, S., Chaudhari, A., & Dwivedi, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22188-0.00016-4
Gıda İşleme ve Üretiminde Yenilikçi Teknolojiler
Aydın, E., Karacabey, E., Küçüköner, E., Özkan, G., Buzrul, S., Baltacıoğlu, H., Coruk, K. S., Doğanay, G., Yetişen, M., Yavuzer, E., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2922
Novel Therapies: Pharmacological Approaches to Modulate the Gut Microbiome in Metabolic Syndrome
Gunjan, & Vidić, J. (2025) · Springer eBooks · doi:10.1007/978-981-96-6246-3_5
Zeng, H., Bai, T., Long, Y., Li, X., Sun, X., Lan, Y., Gao, L., Zhang, L., Feng, Z., & Hou, X. (2019) · Research Square · doi:10.21203/rs.2.13843/v2
Zeng, H., Bai, T., Long, Y., Li, X., Sun, X., Lan, Y., Gao, L., Zhang, L., Feng, Z., & Hou, X. (2019) · Research Square · doi:10.21203/rs.2.13843/v1
Bai, T., Zeng, H., Long, Y., Li, X., Sun, X., Lan, Y., Gao, L., Zhang, L., Feng, Z., & Hou, X. (2020) · Figshare · doi:10.6084/m9.figshare.12592620
Urologic Applications of the Microbiota in Multiple Sclerosis
May, D. N., & Togami, J. M. (2018) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-018-0461-8
The issue of the correct use of probiotics in the absence of recommendations
Tomczak, H., Wrońska, M., Pecyna, P., & Hampelska, K. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.7701
Identificación molecular de la microbiota gastrointestinal del lechón lactante
Domínguez, F. F., Vásquez-Rojas, L., Cuba, M. V. B., Alicia López, F., & Mialhe, M. (2021) · Revista de Veterinaria y Zootecnia Amazónica · doi:10.51252/revza.v1i1.136
Prospects for Probiotic Approach inthe Management of the Oral Ailments: A Review
Regmi, Y., Gyawali, R., Aryal, S., Baby, B., & Adhikari, B. (2021) · International Journal of Pharmacy and Pharmaceutical Research · doi:10.25166/ijppr.2021.v20i04.29
“concerning the safety of probiotics reported that the presently available literature has not satisfactorily evaluated the safety issue [98,99].”
BackgroundMazloom, F., Mottaghizadeh-Jazi, M., Dousari, A. S., Farsinejad, A., & Khanahmad, A. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70421
“Besides systemic infections, Doron and Snydman have listed the principal adverse effects of probiotics, including harmful metabolic complications, excessive immune system stimulation, gene transfer from probiotics to the normal microbial flora, and GI side effects [ 104 ].”
Probiotics and its Application in Humans: An Overview
Arunavarsini, K., Yuvansasi, V. , Sekar, M., Durga Devi., L., & Mahenthiran, R. (2024) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2024/v36i77552
Saavedra, J. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00168-2
THE POTENTIAL USE OF PROBIOTICS TO CURE NEURODEGENERATIVE DISORDER – PARKINSON DISEASE; A REVIEW
(2023) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets40616
Ratna, P., Sarker, A., Ramesh, A. S., Tello, C. M., Jamil, D., Tran, H. H.-V., Mansoor, M., Butt, S. R., Satnarine, T., & Mohammed, L. (2023) · Journal For International Medical Graduates · doi:10.56570/jimgs.v2i1.99
Zhang, Y., Liu, J., Zheng, X., Cheng, H., Xiong, Y., Xie, Y., Fan, B., Liu, W., & Mei, L. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108911
Trends in the Use of Symbiotics in Morocco during the Years 2020 and 2021
Misk, M., Ibrahmi, B. A., Ghouddany, S. E., Ettair, S., Mehdioui, S., & Bour, A. (2023) · Ecological Engineering & Environmental Technology · doi:10.12912/27197050/157535
Fangous, M.-S., Gosset, P., Galakhoff, N., Gouriou, S., Guilloux, C.-A., Payan, C., Vallet, S., Héry-Arnaud, G., & Berre, R. L. (2021) · Figshare · doi:10.6084/m9.figshare.14870369
PROBIOTICS AND THEIR USES IN CLINICAL PRACTICE – AN OVERVIEW
İlktaç, M., Tanjara, H., Öğmen, S., & Çelik, G. (2018) · EMU Journal of Pharmaceutical Sciences
In Vivo Determination of Dermonecrotic Properties
Shah, S. R., Laddha, N. C., & Dwivedi, M. (2025) · Methods and protocols in food science · doi:10.1007/978-1-0716-4758-5_23
Co‐Encapsulated Synbiotics for Improved Human Health
Datten, B., Jangra, N., & Gulati, P. (2026) · Wiley eBooks · doi:10.1002/9781394269082.ch4
Standard and innovative options in the treatment of insulin resistance
Metelski, J., Krauze-Kuc, K., Metelska, A., Sereda, D., & Nieścior, H. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.08.041
Lee, J., Park, E., Lee, S., Yi, H.-C., Lim, S.-D., Elnar, A. G., Kim, G., & Yoon, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2445725/v1
Barraud, D., & Gibot, S. (2016) · Réanimation · doi:10.1007/s13546-016-1196-1
(KID), K., & Gaisser, A. (2018) · Der Onkologe · doi:10.1007/s00761-018-0383-2
Fontaine, R. C., & Pelletier, O. M. (2023) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/ygaayo2qj8
Current evidence on the relationship between gut microbiota (GM) and neurodegenerative diseases
Muñoz, S. C. (2024) · UCrea (University of Cantabria)
Probióticos y microbiota humana: Fundamentos científicos y aplicaciones clínicas
Gamboa, Y. L., & de Aparicio, C. X. P. (2026) · doi:10.64092/zvpb8361
Güncel Periodontoloji Çalışmaları VII
Bayar, B., Yüce, H. B., KAHRAMAN, B., Gürbüz, E., KAVAK, İ., BİNBAŞIOĞLU, D. D., Tirimoğulları, M., Arslan, M. B., ERDİL, Z. B. Ç., KEYSAN, A., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4124
Behn, J., & Klinner, S. (2025) · Springer eBooks · doi:10.1007/978-3-662-70596-4_3
Kim, Y. W., Park, S., Kang, S. J., Lee, M. W., Choi, Y., Kim, B. Y., Choi, M., Shin, C. M., Kim, Y. S., Kim, N., et al. (2026) · Ewha Medical Journal · doi:10.12771/emj.2026.01256
Probiotics as Support for Antibiotic Therapy: Benefits and Risks
Dominiczak, K., Szafrańska, K., Mucha, A., Chodkowska, E., Jakubczyk, N., Leszczyńska-Knaga, E., Graszka, S., Szeps, A., Dominiczak, P., & Bielas, K. (2025) · Quality in Sport · doi:10.12775/qs.2025.41.60214
Výživa - racionálna výživa človeka
Rimárová, K., Babjaková, J., Diabelková, J., Dorko, E., Lovayová, V., Štefková, G., Varga, J., & Zacharová, G. (2025) · doi:10.33542/rvc-040-3-0
Villard, A. (2020) · theses.fr (ABES) · doi:10.70675/f14945bez0129z4664z9e05zf89d7c00e4a7
Brdarić, E. (2023) · IMAGINE - Repository of the Institute of molecular genetics and genetic engineering (University of Belgrade)
Cruz, C. S. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Nouvelle thérapeutique anti-Pseudomonas aeruginosa dans la mucoviscidose : les Lactobacillus spp.
Fangous, M.-S. (2019) · theses.fr (ABES) · doi:10.70675/bbe6a8c0za30ez4497z81b8z9b8412664d3c
Mohammad, S. M. (2020) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Τσεκλίδου, Ε. (2020) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.8303
(2025) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets82907
Metagenomic methods for the analysis of human microbiota towards a clinical application.
Grandi, R. D. (2017) · IrInSubria (University of Insubria)
Consequences of the long-term co-cultivation of Bacillus subtilis and Salmonella Typhimurium
Čerkez, L. T. (2026) · Repository of the University of Ljubljana (University of Ljubljana)
Immunomodulatory Effects of Synbiotic Lactic Acid Bacteria from Dangke and Inulin from Dahlia Tubers
Febriani, A., Hafsan, H., Nur, F., Muthiadin, C., & Khudaer, F. (2025) · Al Jahiz Journal of Biology Education Research · doi:10.32332/al-jahiz.v6i2.10393
Pierro, F. D., Khan, A., Veeraraghavan, G., Kalaivani, P., Ravikumar, S., Tanda, M. L., Zerbinati, N., Carugno, A., & Ujjan, I. (2026) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2512.12003
Amat, S. (2019) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/37278
Sustainable Animal Agriculture - Global Challenges and Practical Solutions
Babinszky, L., & Nikkhah, A. (2025) · Agricultural sciences. · doi:10.5772/intechopen.1005726
El-Sayed, S. E. (2026) · Folia Microbiologica · doi:10.1007/s12223-026-01492-4
Ormer, M. V. (2023) · DigitalCommons@UNMC
'Lactobacillus fermentum' 3872 genome sequencing and analysis
Lehri, B. (2017) · Research Repository (Kingston University London)
INSAC Academic Developments on Health Sciences
Öztürk, B., KAZAN, E. E., ÖZKAN, B., Bodur, İ., Karşıgil, P., Erişti, E. D., & Gümüş, G. (2021) · AYBU AVESIS
Yang, W., Yang, Y., Dai, R. H., Ou, Y., Hong, T., Li, Z., Zhu, Y., Ni, H., Jiang, Z., & Zheng, M. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108879
Deshmukh, A., Deshmukh, A. A., Buva, K. B., Rai, P., Gaikwad, R. P., Attar, N., Seshadri, V., Kakarmath, S. V., & Awasare, P. G. (2025) · Journal of Dentistry and Bio-Allied Health Sciences · doi:10.5005/jdbahs-11017-0030
Ko, G., Park, M. H., Jo, H., Lee, E., & Kim, C.-S. (2025) · Journal of Applied Biological Chemistry · doi:10.3839/jabc.2025.031
Bacteremia por Bacillus clausii em paciente adulto: relato de caso
Silva, M. C. F., Wanderley, E. V. B., Lucena, M. S., & Martins, A. G. S. (2025) · Journal Archives of Health · doi:10.46919/archv6n1-009
Jackson, H. S. (2026) · Journal of Kidney Care · doi:10.12968/jokc.2025.0007
Вовед во токсикологија на храна
Kavrakovski, Z. (2026) · doi:10.55302/m435379k
Multi-drug Resistant Enterococcus faecalis isolated from animal and human sources
Radwan, I., EL-Gendy, A. O., Mohamed, M. F., & Mohsen, N. (2018) · Journal of Veterinary Medical Research · doi:10.21608/jvmr.2018.43310
“Theoretically, risks associated with the use of probiotics in animal feed are gastrointestinal or systemic infection of the animal fed the probiotic and consumers of the animal products and transfer of antibiotic resistance for probiotics to other pathogenic microorganisms (Doron and Snydman, 2015).”
Uso de probióticos do gênero dos lactobacillus e seus eventos adversos em pacientes críticos
Amâncio, A. K. A., & Rodrigues, A. L. D. A. R. (2022) · doi:10.22482/dspace/13
Coelho, B. D. O. (2018) · Repositório Digital Institucional da UFPR (Universidade Federal do Paraná)
Casula, E. (2021) · UNICA IRIS Institutional Research Information System (University of Cagliari)
da Silva, T. N. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Oğuz, S., Tam, N., Aydoğdu, A., ŞÜMNÜ, S. G., & Şahin, S. (2019) · OpenMETU (Middle East Technical University)
Comparison and analysis of the familiarity of lay and professional public with probiotics
Lorenčič, D. (2024) · University of Maribor digital library (University of Maribor)
Satoshi, A., サトシ, ア., & Satoshi, A. (2019) · Institutional Repositories DataBase (IRDB) · doi:10.20604/00002795
Overholt, T. L., Lor, L. S., & Mirzazadeh, M. (2021) · Journal of Urology and Renal Diseases · doi:10.29011/2575-7903.001234
“This point is especially important given the risks associated with problematic, recurrent antimicrobial use, with a variety of serious and potentially life threatening side effects observed in this patient population [24,25].”
BackgroundVarshney, K. (2021) · Asian Journal of Multidimensional Research · doi:10.5958/2278-4853.2021.00855.7
Potentiality of Probiotics in Inactivation of Tetrodotoxin
Nath, R. P., & Kundu, J. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8990-1_1
(2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6
EMPOWERMENT AS AN OUTCOME IN THE SELF-MANAGEMENT OF CHRONIC ILLNESS: A CROSS-SECTIONAL STUDY
Luz, E., Bastos, F. D. S., & Vieira, M. M. S. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_1
Atresia Intestinal Tipo IV y sus Complicaciones: Presentación de un Caso
Carrillo, C. T., Castillo, M. M. C., Correa, A. J. C., & Edith, M. Y. C. (2025) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v9i1.16283
Probiotic Integration in Diarrheal Management – A Digital Campaign Analysis Using the Hidoc Platform
Shaikh, A., Gholap, S., Gadia, V., & Mullick, A. (2025) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.6.0325.1235
Probiotics in Prosthodontics: A Paradigm Shift in Oral Health
Nair, V. V. (2025) · The Journal of Prosthetic and Implant Dentistry · doi:10.55231/jpid.2025.v08.i02.00
The Role of Probiotics and Prebiotics in Periodontal Health: A Literature Review
Jassim, A. A., & Akram, H. M. (2025) · Scholars Journal of Dental Sciences · doi:10.36347/sjds.2025.v12i08.001
Campos-Miño, S., Sevillano, G., Herrera, A., Ramírez Iglesias, J. R., & Zurita, J. (2025) · Siembra
ÖRTLEK, O. (2025) · eArsiv - Adu (Adnan Menderes University)
The effect of probiotics on the course of crohn´s disease
Trobentar, M. (2024) · University of Maribor digital library (University of Maribor)
Les probiotiques : une alternative aux antibiotiques dans le traitement d'une parodontite ?
Bierry, Q. (2023) · HAL
ANESTESIA PARA INTERVENÇÃO CIRÚRGICA ENDOVASCULAR NA AORTA ABDOMINAL: REVISÃO
Lima, R. L., Oliveira, M. P., Silvestre, M. M., & Barbosa, R. P. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_6
da Silva, R. F. P., Tátero, G. R., Siqueira, B. A., Barbosa, K. K. S., & Filho, N. N. C. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_7
USO DO ÁCIDO TRANEXÂMICO E SEU IMPACTO NA SOBREVIDA DO TRAUMA
Ferreira, A. F. D. J., & Souza, L. B. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_4
A PREVALÊNCIA DE LESÕES EM LUTADORES DE MUAY THAI
Martins, A. C., Amorim, A. C., & da Silveira, A. M. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_3
INSUFICIÊNCIA DE VITAMINA D E OBESIDADE INFANTIL
Sallati, I., & Bernardes, C. F. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_2
D’Umbra, I. C., & Lorenzato, P. C. O. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_9
EFEITOS DA EXPOSIÇÃO À ALTITUDE SOBRE OS ASPECTOS NEUROPSICOLÓGICOS: UMA REVISÃO DA LITERATURA
Júnior, W. D. S. P., Silva, R. R., Carneiro, P. H. G., de Aguiar, L. C., & D’Umbra, I. C. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_8
NEUROFIBROMA ORBITÁRIO ISOLADO E ENDOTROPIA: REVISÃO DE LITERATURA
Neuenschwander, G. O., Romão, J. V., Bueno, G. G. G. R., Lima, N. D. N., & de Oliveira, F. R. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_5
ANEURISMA GIGANTE DE ARTÉRIA ESPLÊNICA: ASPECTOS DE IMAGEM E DESAFIO TERAPÊUTICO
Souza, F. A., Machado, T. M. N., de Araújo, E. O., de Oliveira, G. L., Guimarães, M. D., & Leite, P. P. M. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_10
Coelho, E. B. S. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Meza, M. G. S. (2021) · Repositorio Institucional FULL
BACTEREMIA POR BACILLUS CLAUSII EM PACIENTE ADULTO: RELATO DE CASO
Silva, M. C. F., Wanderley, E. V. B., Lucena, M. S., & Martins, A. B. M. (2025) · Latin American Publicações eBooks · doi:10.47174/lap2020.ed.978-65-85645-09-6_11
BIOPROSPECÇÃO DE LEVEDURAS COM POTENCIAL PROBIÓTICO ISOLADAS DO FRUTO DO JAMBOLÃO (SYZYGIUM CUMINI)
Durão, G. G., Silva, J. F. M., Cavalcante, J. M. C., Barros, V. L. B., & Silva, D. L. D. S. (2026) · DESAFIOS Revista Interdisciplinar da Universidade Federal do Tocantins · doi:10.20873/vol13n3pibic202523
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.